Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 11 is classified as a pseudogene related to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 (MT-ND6) gene. Pseudogenes are DNA sequences similar to known genes but non-functional, typically due to mutations or lack of regulatory elements. MTND6P11 does not encode a protein product, play a role in oxidative phosphorylation, or participate in mitochondrial respiratory function. All functional and disease-relevant roles are attributed to the MT-ND6 gene, not this pseudogene[1][2]. The confusion may arise from conflation of MTND6P11 with the functional MT-ND6 gene, which is a protein-coding gene vital for mitochondrial electron transport and ATP generation, and is associated with certain mitochondrial diseases such as Leber hereditary optic neuropathy and Leigh syndrome[1][2]. MTND6P11 has no known functional or therapeutic relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 11 (MTND6P11).